- Home
- DLB vs ASND Comparison
DLB vs ASND Comparison
Compare DLB & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DLB
- ASND
- Stock Information
- Founded
- DLB 1965
- ASND 2006
- Country
- DLB United States
- ASND Denmark
- Employees
- DLB N/A
- ASND N/A
- Industry
- DLB Multi-Sector Companies
- ASND Biotechnology: Pharmaceutical Preparations
- Sector
- DLB Miscellaneous
- ASND Health Care
- Exchange
- DLB Nasdaq
- ASND Nasdaq
- Market Cap
- DLB 7.9B
- ASND 9.8B
- IPO Year
- DLB 2005
- ASND 2015
- Fundamental
- Price
- DLB $74.24
- ASND $162.84
- Analyst Decision
- DLB Strong Buy
- ASND Strong Buy
- Analyst Count
- DLB 4
- ASND 16
- Target Price
- DLB $101.75
- ASND $213.88
- AVG Volume (30 Days)
- DLB 387.6K
- ASND 477.8K
- Earning Date
- DLB 05-01-2025
- ASND 05-01-2025
- Dividend Yield
- DLB 1.78%
- ASND N/A
- EPS Growth
- DLB 36.08
- ASND N/A
- EPS
- DLB 2.64
- ASND N/A
- Revenue
- DLB $1,320,184,000.00
- ASND $398,509,511.00
- Revenue This Year
- DLB $6.38
- ASND $76.03
- Revenue Next Year
- DLB $4.65
- ASND $74.19
- P/E Ratio
- DLB $28.12
- ASND N/A
- Revenue Growth
- DLB 4.03
- ASND 12.06
- 52 Week Low
- DLB $66.35
- ASND $111.09
- 52 Week High
- DLB $89.66
- ASND $183.00
- Technical
- Relative Strength Index (RSI)
- DLB 42.61
- ASND 53.99
- Support Level
- DLB $74.47
- ASND $156.56
- Resistance Level
- DLB $75.63
- ASND $163.55
- Average True Range (ATR)
- DLB 0.84
- ASND 6.04
- MACD
- DLB -0.18
- ASND 0.09
- Stochastic Oscillator
- DLB 9.04
- ASND 80.88
About DLB Dolby Laboratories
Dolby Laboratories Inc develops audio and surround sound for cinema, broadcast, home audio systems, in-car entertainment systems, DVD players, games, televisions, and personal computers. The company designs and manufactures audio, imaging, accessibility, and other hardware and software solutions for the cinema, with occasional applications in the television, broadcast, and live entertainment industries. The company operates in the United States and internationally.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.